The polymethoxylated flavone hexamethylquercetagetin suppresses NF-κB signaling and inhibits cell survival in cervical carcinoma

References

• Altoos, B., C. Small, P. Dalal, D. Attieh, S. El Achy, V. Parimi, J. J. Wei, et al. 2020. “Prognostic Significance of Nuclear Factor Kappa B Expression in Locally Advanced Cervical Cancer Patients Treated Definitively with Concurrent Chemoradiation.” American Journal of Clinical Oncology 43 (1): 47–51. doi:10.1097/coc.0000000000000626.
   PubMed Web of Science ®Google Scholar
• Amrutha, K., P. Nanjan, S. K. Shaji, D. Sunilkumar, K. Subhalakshmi, L. Rajakrishna, and A. Banerji. 2014. “Discovery of Lesser Known Flavones as Inhibitors of NF-κB Signaling in MDA-MB-231 Breast Cancer Cells–A SAR Study.” Bioorganic & Medicinal Chemistry Letters 24 (19): 4735–4742. doi: 10.1016/j.bmcl.2014.07.093.
   PubMed Web of Science ®Google Scholar
• Baek, Sohee, Nam Joo Kang, Grzegorz. M. Popowicz, Marcelino Arciniega, Sung Keun Jung, Sanguine Byun, Nu Ry Song, et al. 2013. “Structural and Functional Analysis of the Natural JNK1 Inhibitor Quercetagetin.” Journal of Molecular Biology 425 (2): 411–423. doi: 10.1016/j.jmb.2012.10.019.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., E. P. Reddy, K. M. Shokat, and L. Soucek. 2017. “Drugging the ‘Undruggable’ Cancer Targets.” Nature Reviews. Cancer 17 (8): 502–508. doi: 10.1038/nrc.2017.36.
   PubMed Web of Science ®Google Scholar
• Dang, G., W. Wu, H. Zhang, and N. Everaert. 2021. “A New Paradigm for a New Simple Chemical: Butyrate & Immune Regulation.” Food & Function 12 (24): 12181–12193. doi: 10.1039/d1fo02116h.
   PubMed Web of Science ®Google Scholar
• Delaney, B., K. Phillips, D. Buswell, B. Mowry, D. Nickels, D. Cox, H. B. Wang, and J. Manthey. 2001. “Immunotoxicity of a Standardized Citrus Polymethoxylated Flavone Extract.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 39 (11): 1087–1094. doi:10.1016/s0278-6915(01)00058-8.
   PubMed Web of Science ®Google Scholar
• Delaney, B., K. Phillips, C. Vasquez, A. Wilson, D. Cox, H. B. Wang, and J. Manthey. 2002. “Genetic Toxicity of a Standardized Mixture of Citrus Polymethoxylated Flavones.” Food and Chemical Toxicology 40 (5): 617–624. doi: 10.1016/s0278-6915(02)00007-8.
   PubMed Web of Science ®Google Scholar
• Elshami, Mohamedraed, Mariam Thalji, Hanan Abukmail, Ibrahim Al-Slaibi, Mohammed Alser, Afnan Radaydeh, Alaa Alfuqaha, et al. 2021. “Knowledge of Cervical Cancer Risk Factors among Palestinian Women: A National Cross-sectional Study.” BMC Women’s Health 21 (1): 385. doi:10.1186/s12905-021-01510-2.
   PubMed Web of Science ®Google Scholar
• Fontham, E. T. H., A. M. D. Wolf, T. R. Church, R. Etzioni, C. R. Flowers, A. Herzig, C. E. Guerra, et al. 2020. “Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society.” CA: A Cancer Journal for Clinicians 70 (5): 321–346. doi:10.3322/caac.21628.
   PubMed Web of Science ®Google Scholar
• Gilmore, Thomas D. 2021. “NF-κB and Human Cancer: What Have We Learned over the past 35 Years?” Biomedicines 9 (8): 889. doi:10.3390/biomedicines9080889.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., and M. R. Garbati. 2011. “Inhibition of NF-κB Signaling as a Strategy in Disease Therapy.” Current Topics in Microbiology and Immunology 349: 245–263. doi: 10.1007/82_2010_105.
   PubMed Web of Science ®Google Scholar
• Hayden, Matthew S., and Sankar Ghosh. 2014. “Regulation of NF-κB by TNF Family Cytokines.” Seminars in Immunology 26 (3): 253–266. doi: 10.1016/j.smim.2014.05.004.
   PubMed Web of Science ®Google Scholar
• Li, Chao, Yanfei Li, Lanxia Sui, Jian Wang, and Fang Li. 2019. “Phenyllactic Acid Promotes Cell Migration and Invasion in Cervical Cancer via IKK/NF-κB-mediated MMP-9 Activation.” Cancer Cell International 19 (1): 241. doi: 10.1186/s12935-019-0965-0.
   PubMed Web of Science ®Google Scholar
• Liu, Hong, Ruiyi Xu, Chun Gao, Tong Zhu, Liting Liu, Yifan Yang, Haihong Zeng, Yafei Huang, and Hui Wang. 2021. “Metabolic Molecule PLA2G2D is a Potential Prognostic Biomarker Correlating with Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.” Frontiers in Oncology 11: 755668. doi: 10.3389/fonc.2021.755668.
   PubMedGoogle Scholar
• Liu, H., X. Ye, D. Li, Q. Yao, and Y. Li. 2021. “Incidence, Clinical Risk and Prognostic Factors for Liver Metastasis in Patients with Cervical Cancer: A Population-based Retrospective Study.” BMC Cancer 21 (1): 421. doi: 10.1186/s12885-021-08127-6.
   PubMed Web of Science ®Google Scholar
• Mirzaei, Sepideh, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Adnan Ranjbar, Seyed Hesam Seyed Saleh, et al. 2021. “Regulation of Nuclear Factor-kappaB (NF-κB) Signaling Pathway by Non-coding RNAs in Cancer: Inhibiting or Promoting Carcinogenesis?” Cancer Letters 509: 63–80. doi: 10.1016/j.canlet.2021.03.025.
   PubMed Web of Science ®Google Scholar
• Song, B., C. Ding, W. Chen, H. Sun, M. Zhang, and W. Chen. 2017. “Incidence and Mortality of Cervical Cancer in China, 2013.” Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu 29 (6): 471–476. doi: 10.21147/j.issn.1000-9604.2017.06.01.
   PubMed Web of Science ®Google Scholar
• Sugawara, Y., I. Tsuji, T. Mizoue, M. Inoue, N. Sawada, K. Matsuo, H. Ito, et al. 2019. “Cigarette Smoking and Cervical Cancer Risk: An Evaluation Based on a Systematic Review and Meta-analysis among Japanese Women.” Japanese Journal of Clinical Oncology 49 (1): 77–86. doi: 10.1093/jjco/hyy158.
   PubMed Web of Science ®Google Scholar
• Sun, S. C. 2017. “The Non-canonical NF-κB Pathway in Immunity and Inflammation.” Nature Reviews. Immunology 17 (9): 545–558. doi: 10.1038/nri.2017.52.
   PubMed Web of Science ®Google Scholar
• Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 71 (3): 209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Taniguchi, K., and M. Karin. 2018. “NF-κB, Inflammation, Immunity and Cancer: Coming of Age.” Nature Reviews. Immunology 18 (5): 309–324. doi: 10.1038/nri.2017.142.
   PubMed Web of Science ®Google Scholar
• Tewari, K. S., and B. J. Monk. 2019. “Evidence-based Treatment Paradigms for Management of Invasive Cervical Carcinoma.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 37 (27): 2472–2489. doi: 10.1200/jco.18.02303.
   PubMed Web of Science ®Google Scholar
• Tilborghs, Sam., Jerome Corthouts, Yannick Verhoeven, David Arias, Christian Rolfo, Xuan Trinh, and Peter van Dam. 2017. “The Role of NF-kB Signaling in Human Cervical Cancer.” Critical Reviews in Oncology/Hematology 120: 141–150. doi: 10.1016/J.critrevonc.2017.11.01.
   PubMed Web of Science ®Google Scholar
• van Meir, H., G. G. Kenter, J. Burggraaf, J. R. Kroep, M. J. Welters, C. J. Melief, S. H. van der Burg, and M. I. van Poelgeest. 2014. “The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-immunotherapy.” Anti-cancer Agents in Medicinal Chemistry 14 (2): 190–203. doi: 10.2174/18715206113136660372.
   PubMed Web of Science ®Google Scholar
• Xia, Yifeng, Shen , and Inder M. Verma. 2014. “NF-κB, an Active Player in Human Cancers.” Cancer Immunology Research 2 (9): 823–830. doi: 10.1158/2326-6066.CIR-14-0112.
   PubMed Web of Science ®Google Scholar
• Yu, Jian-shuai, Jin , and Yi-yuan Li. 2020. “The Physiological Functions of IKK-selective Substrate Identification and Their Critical Roles in Diseases.” STEMedicine 1 (4): e49. doi: 10.37175/stemedicine.v1i4.49.
   Google Scholar